MATTHEW SCHWEDLER: Open Payments
NPI 1609827179 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,194 in 97 payments from 18 companies in 2025. Trend: 2023 $2,676 · 2024 $1,762 · 2025 $2,194
Food & beverage: $2,194
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $366 |
| GENZYME CORPORATION | 14 | $296 |
| Regeneron Healthcare Solutions, Inc. | 10 | $280 |
| Arcutis Biotherapeutics, Inc. | 15 | $189 |
| Incyte Corporation | 7 | $171 |
| UCB, Inc. | 6 | $171 |
| Amgen Inc. | 3 | $154 |
| Organon LLC | 11 | $153 |
| E.R. Squibb & Sons, L.L.C. | 2 | $78 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $60 |
Products named: DUPIXENT, SKYRIZI, Zoryve, OPZELURA, Bimzelx, RINVOQ, Repatha, VTAMA.
Industry payments across MI — which companies pay providers there.
